FindTrial
Sign In

how common is loss of muscle mass and strength in patients with liver disease and does it affect recovery after liver transplant

Prevalence of sarcopenia and its impact on post transplant outcomes - PSILT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023294
Enrollment
110
Registered
2020-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with cirrhosis posted for elective living donor liver transplant.

Exclusion criteria

Exclusion criteria: Pediatric liver transplant(age less than 18 yrs), Acute liver failure

Design outcomes

Primary

MeasureTime frame
Prevalence of sarcopenia in patients posted for living donor liver transplantTimepoint: day(-1)—

Secondary

MeasureTime frame
Need for re-intubationTimepoint: Between Post operative Day 1 to post operative day 30(POD1 to POD30);No. of days of ventilatory supportTimepoint: Between Post operative Day 1 to post operative day 30(POD1 to POD30);Number of ICU stayTimepoint: Between Post operative Day 1 to post operative day 30(POD1 to POD30);Occurrence of patients developing culture positive sepsisTimepoint: Between Post operative Day 1 to post operative day 30(POD1 to POD30);Post-Operative mortalityTimepoint: Between Post operative Day 1 to post operative day 30(POD1 to POD30)—

Countries

India

Contacts

Public ContactDr Shweta A Singh

Max Super Speciality Hospital

drshwetasingh29@gmail.com9810625177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026